Taiwan FDA registration 83399a700bfbb245168cc7358821af82
Innova anti-cardiac lipid antibody immunoglobulin M enzyme linkage face analysis test system
TW: 因諾瓦抗心脂質抗體免疫球蛋白M酵素連結面液分析法檢驗系統
Taiwan·Risk Class 2·INOVA DIANOSTICS, INC.·Registered Dec 08, 2005 – Dec 08, 2025ExpiredRegistration details
- Analysis ID
- 83399a700bfbb245168cc7358821af82
- Customs Code
- DHA00601533904
Company information
- Manufacturer
- INOVA DIANOSTICS, INC.
- Manufacturer Country
- United States
- Authorized Representative
- TRUGENE DIAGNOSTICS, INC.
Product details
- Intended Use
- Immunoenzyme method was used to carry out semi-quantitative detection of immunoglobulin M anticardiolipid antibody in human serum sample.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5100 抗核抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 08, 2005
- Expiry Date
- Dec 08, 2025
About this record
Access comprehensive regulatory information for Innova anti-cardiac lipid antibody immunoglobulin M enzyme linkage face analysis test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 83399a700bfbb245168cc7358821af82 and manufactured by INOVA DIANOSTICS, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices